Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | IDE | P14735 | 1/20 | 0.57 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | BLVRB | P30043 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | NME4 | O00746 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6812006 | 1.00 | MEN1 (0.60) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL6806137 | 0.88 | MEN1 (0.53) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL6806141 | 0.88 | MEN1 (0.53) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL13905008 | 0.86 | MEN1 (0.59) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL5418556 | 0.85 | MEN1 (0.50) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL5418560 | 0.85 | MEN1 (0.50) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL10834454 | 0.84 | MEN1 (0.50) | MEN1KMT2AMAPTL3MBTL1PDE4A | |
| SCHEMBL10834457 | 0.84 | MEN1 (0.50) | MEN1KMT2AMAPTL3MBTL1PDE4A | |
| SCHEMBL10834243 | 0.84 | MAPT (0.56) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL10834238 | 0.84 | MAPT (0.56) | MEN1KMT2AMAPTNPSR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040067229-A1 | Azobenzene derivatives as labeling agents and intermediates thereof | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067229-A1 | Azobenzene derivatives as labeling agents and intermediates thereof | CBR1, CBR3, HBB | MEN1 2043/4885KMT2A 1572/4885MAPT 2644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.